文献速递血栓与止血

活化凝血因子VII通过激活酸性鞘磷脂酶从内皮细胞释放富含磷脂酰丝氨酸的细胞外囊泡

Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase.
PubMed 文献 · J Thromb Haemost · 2023-10-22

本研究探讨活化凝血因子VII(FVIIa)诱导内皮细胞释放富含磷脂酰丝氨酸(PS)的细胞外囊泡(EVs)的机制。研究发现FVIIa激活酸性鞘磷脂酶(aSMase)是PS外化和EVs释放的关键,aSMase缺陷小鼠中FVIIa释放EVs受损,且低剂量FVIIa纠正血小板减少相关出血的作用在aSMase缺陷小鼠中丧失。

要点

  • FVIIa激活aSMase导致PS外化和EVs释放。
  • aSMase缺陷小鼠中FVIIa释放EVs明显受损。
  • 低剂量FVIIa纠正血小板减少出血依赖aSMase。

核心结论

  • 本研究揭示FVIIa通过激活aSMase诱导PS外化并释放富含PS的EVs的新机制。

研究设计与样本

  • 体外内皮细胞实验结合野生型与aSMase-/-小鼠体内实验,使用特异性siRNA和抑制剂,通过纳米颗粒跟踪分析定量EVs,并在小鼠血小板减少模型中评估止血潜力。

主要发现

  • FVIIa激活aSMase负责内皮细胞PS外化和EVs释放。
  • FVIIa诱导的aSMase激活导致神经酰胺生成和跨膜蛋白16F的从头表达。
  • 神经酰胺酶、鞘氨醇激酶或鞘氨醇-1-磷酸受体调节剂的抑制剂阻断FVIIa诱导的跨膜蛋白16F表达和PS外化,但不干扰FVIIa释放EVs。
  • 在体内,与野生型小鼠相比,aSMase-/-小鼠中FVIIa释放EVs明显受损。
  • 给予足以诱导EVs释放的低剂量FVIIa可纠正野生型小鼠的血小板减少相关出血,但在aSMase-/-小鼠中不能纠正。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our recent studies showed that activated factor (F) VII (FVIIa) releases extracellular vesicles (EVs) from the endothelium. FVIIa-released EVs were found to be enriched with phosphatidylserine (PS) and contribute to the hemostatic effect of FVIIa in thrombocytopenia and hemophilia. OBJECTIVE: To investigate mechanisms by which FVIIa induces EV biogenesis and enriches EVs with PS. METHODS: FVIIa activation of acid sphingomyelinase (aSMase) was evaluated by its translocation to the cell surface. The role of aSMase in the biogenesis of FVIIa-induced EVs and their enrichment with PS was investigated using specific siRNAs and inhibitors of aSMase and its downstream metabolites. Wild-type and aSMase-/- mice were injected with a control vehicle or FVIIa. EVs released into circulation were quantified by nanoparticle tracking analysis. EVs hemostatic potential was assessed in a murine thrombocytopenia model. RESULTS: FVIIa activation of aSMase is responsible for both the externalization of PS and the release of EVs in endothelial cells. FVIIa-induced aSMase activation led to ceramide generation and de novo expression of transmembrane protein 16F. Inhibitors of ceramidases, sphingosine kinase, or sphingosine-1-phosphate receptor modulator blocked FVIIa-induced expression of transmembrane protein 16F and PS externalization without interfering with FVIIa release of EVs. In vivo, FVIIa release of EVs was markedly impaired in aSMase-/- mice compared with wild-type mice. Administration of a low dose of FVIIa, sufficient to induce EVs release, corrected bleeding associated with thrombocytopenia in wild-type mice but not in aSMase-/- mice. CONCLUSION: Our study identifies a novel mechanism by which FVIIa induces PS externalization and releases PS-enriched EVs.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Das K, Keshava S, Mukherjee T, et al. Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase. J Thromb Haemost. 2023. PMID: 37875382. doi:10.1016/j.jtha.2023.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。